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Abstract: Signal transduction pathways enable organisms to monitor their external environment
and adjust gene regulation to appropriately modify their cellular processes. Second messenger
nucleotides including cyclic adenosine monophosphate (c-AMP), cyclic guanosine monophosphate
(c-GMP), cyclic di-guanosine monophosphate (c-di-GMP), and cyclic di-adenosine monophosphate
(c-di-AMP) play key roles in many signal transduction pathways used by prokaryotes and/or
eukaryotes. Among the various second messenger nucleotides molecules, c-di-AMP was discovered
recently and has since been shown to be involved in cell growth, survival, and regulation of
virulence, primarily within Gram-positive bacteria. The cellular level of c-di-AMP is maintained
by a family of c-di-AMP synthesizing enzymes, diadenylate cyclases (DACs), and degradation
enzymes, phosphodiesterases (PDEs). Genetic manipulation of DACs and PDEs have demonstrated
that alteration of c-di-AMP levels impacts both growth and virulence of microorganisms. Unlike
other second messenger molecules, c-di-AMP is essential for growth in several bacterial species as
many basic cellular functions are regulated by c-di-AMP including cell wall maintenance, potassium
ion homeostasis, DNA damage repair, etc. c-di-AMP follows a typical second messenger signaling
pathway, beginning with binding to receptor molecules to subsequent regulation of downstream
cellular processes. While c-di-AMP binds to specific proteins that regulate pathways in bacterial cells,
c-di-AMP also binds to regulatory RNA molecules that control potassium ion channel expression
in Bacillus subtilis. c-di-AMP signaling also occurs in eukaryotes, as bacterially produced c-di-AMP
stimulates host immune responses during infection through binding of innate immune surveillance
proteins. Due to its existence in diverse microorganisms, its involvement in crucial cellular activities,
and its stimulating activity in host immune responses, c-di-AMP signaling pathway has become an
attractive antimicrobial drug target and therefore has been the focus of intensive study in several
important pathogens.
Keywords: c-di-AMP; Gram-positive bacteria; c-di-AMP synthesis and degradation;
c-di-AMP-binding proteins
1. Introduction
Living organisms receive and process environmental stimuli through signal transduction
pathways and respond through differential regulation of various cellular processes. Cyclic nucleotides
that act as second messenger molecules play key roles in signaling pathways that sense environmental
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changes such as stress, temperature, nutrition, and pH in both prokaryotes and eukaryotes [1–3].
As second messengers, these cyclic nucleotides are involved in the transmission of the signals to
effector molecules [1,4].
The original second messenger molecule discovered was cyclic adenosine monophosphate
(cAMP) through its role in metabolic pathways of eukaryotes, specifically, mammalian hormonal
regulation [5,6]. Since its initial discovery, cAMP has been found to act as a second messenger in a
variety of organisms including many bacterial species and has diverse activity including roles in biofilm
formation, expression of virulence factors, motility, and carbon metabolism [7]. Subsequently, several
additional cyclic nucleotide second messengers have been discovered including cyclic guanosine
monophosphate (cGMP), cyclic di-guanosine monophosphate (c-di-GMP), cyclic di-adenosine
monophosphate (c-di-AMP), and cyclic guanosine monophosphate-adenosine monophosphate
(cGAMP) in a wide variety of organisms [2,8,9]. cGMP and c-di-GMP have been well characterized,
particularly in Gram-negative bacteria. cGMP is involved in chemotaxis and UV stress-response, while
c-di-GMP facilitates the transition from motile phase to adhesive phase and the expression of fimbriae
in bacteria [3].
c-di-AMP is a new addition to the growing list of second messenger nucleotides and has
since been identified in Gram-positive bacteria including Listeria monocytogenes, Bacillus subtilis,
Staphylococcus aureus, and Streptococcus spp., and in a few Gram-negative bacteria including
Chlamydia trachomatis and Borrelia burgdorferi [1,10–16]. c-di-AMP has been implicated in diverse
essential cellular processes including cell wall and membrane homeostasis, regulation of potassium ion
channels, DNA damage repair, and sporulation (Table 1). Though c-di-AMP has been shown to play a
critical role in many human pathogenic bacteria, neither its environmental stimuli nor the mechanisms
controlling the regulation of cellular physiology and virulence are well understood [15,17].
Table 1. The function of cyclic di-adenosine monophosphate (c-di-AMP) and its synthesis and
degradation enzymes in bacteria.
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c-di-AMP was first identified in a study of the DNA repair mechanism in Thermotoga maritima [29],
and later, the same role of c-di-AMP in DNA repair was identified in B. subtilis [18,29]. In a separate line
of research, c-di-AMP was isolated from the cytosol of L. monocytogenes-infected host cells that were
producing elevated levels of interferon β [16]. Interferon β is secreted by immune cells in response to
infection by microorganisms, and it induces the innate immune response in the host. The correlation
between the presence of c-di-AMP and the higher level of interferon β expression indicated that
c-di-AMP plays a role in eliciting an immune response in the infected host. Because many human
pathogenic Gram-positive bacteria such as Mycobacterium tuberculosis, Streptococcus pyogenes, S. aureus,
and L. monocytogenes produce c-di-AMP, the signaling pathway has recently become an attractive drug
target [30]. c-di-AMP is essential for the growth of many Gram-positive bacteria such as S. aureus,
L. monocytogenes and B. subtilis, so complete depletion of c-di-AMP by deleting the diadenylate cyclase
genes in those bacteria leads to the lethal phenotype under standard lab growth conditions unless a
special medium is provided, or a suppressor mutation develops [31,32]. On the contrary, the deletion
of the diadenylate cyclase gene in Streptococcus mutans, cdaA was not lethal, suggesting that some
bacteria can survive in the absence of c-di-AMP [24].
Interestingly, although some bacteria such as B. subtilis and L. monocytogenes produce both
c-di-AMP and c-di-GMP, S. aureus and S. pyogenes are unable to synthesize c-di-GMP since they
lack c-di-GMP synthesizing enzymes [26]. Although most second messenger molecules utilize similar
mechanisms in their signaling pathways, their contributions to cell physiology and function differ
greatly. Each of the second messenger nucleotides bind to different sets of proteins or RNA molecules,
which thereby regulate distinct cellular processes [17]. c-di-AMP works in the signaling pathway in
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a manner similar to other second messenger molecules such as c-di-GMP, cAMP, and cGMP, but the
environmental stimuli and detailed mechanisms are not yet known.
2. Synthesis of c-di-AMP
In contrast to the variety of GGDEF domain-containing proteins that synthesize c-di-GMP [33],
only a few c-di-AMP synthesizing enzymes have thus far been discovered in bacteria and
archaea. These c-di-AMP synthesizing enzymes are found primarily in Gram-positive Firmicutes
and Actinobacteria but are also present in some Gram-negative bacteria including Bacteroidetes,
Deltaproteobacteria, and Cyanobacteria [3]. Moreover, the signaling pathways for c-di-GMP and
c-di-AMP rarely co-exist in the same organisms. For example, Staphylococcus, Streptococcus, and
Corynebacterium species do not contain functional c-di-GMP synthesizing enzymes [17,34,35]. Notable
exceptions to this rule include Bacillus, Clostridium, Listeria, Mycobacterium, and Streptomyces, which
produce both signaling molecules [3,32].
c-di-AMP is synthesized from ATP or ADP by cyclase domain-containing proteins known as
diadenylate cyclases (DACs) (Figure 1). DAC enzymes catalyze the synthesis of a single molecule
of c-di-AMP from two molecules of ATP or ADP through a condensation reaction [3,14,32,34,35].
Structural and functional analysis of individual DAC domains and operons have enhanced the current
understanding of the functions of the various classes of these proteins [32,35]. The DAC domain
was first identified by X-ray crystallography in DisA (DNA integrity scanning protein A), which
functions as a DNA check point protein scanning the chromosome for lesions [18,29]. Later, DAC
domain-containing proteins were found in many bacterial and archaeal species [34]. Four classes
of DACs have been identified: DisA, CdaA, CdaS, and CdaM. While most organisms contain only
one type of DAC, some contain multiple enzymes including Clostridium spp., which contain two
types of DACs (CdaA and DisA) and B.subtilis, which has DisA, CdaA, and CdaS [36]. Several
Gram-positive human pathogenic bacteria including S. pyogenes, S. pneumoniae, and L. monocytogenes
encode CdaA [14,16,25] while M. tuberculosis expresses MtDisA, a DisA homolog [11,37]. Previous
studies have demonstrated that DAC mutant strains display altered physiologies such as loss of
resistance to heat, salt, and DNA-damaging molecules due to the synthesis of a weak cell wall, making
the bacteria vulnerable to its environment [15,32]. The impact of DAC on numerous aspects of cell
physiology highlights the essential nature of DACs in bacteria [15,19,29,32].
All DAC domain proteins possess conserved motifs, most commonly DGA and RHR motifs, which
perform the cyclase activity in the c-di-AMP synthesis reactions [38,39]. However, these domains do not
share any structural or amino acid similarities with the GGDEF domain found in c-di-GMP-catalyzing
enzymes suggesting these signaling pathways evolved independently [40]. Structural analysis of the
three types of DACs have demonstrated that the DAC domains in CdaA and CdaS share 40% amino
acid identity, while the DAC domain in the DisA protein is more distantly related, sharing only 19%
identity with CdaA and CdaS [32,34]. The association of neighboring genes with each class of DAC
points to the physiological role of the c-di-AMP. For example, the association of cdaA with a gene
that encodes an enzyme synthesizing a cell wall building block (glmM) suggests a role for CdaA and
c-di-AMP in the maintenance of cell wall homeostasis [32,34].
2.1. DisA
DisA, crystalized from Thermotoga maritima, was the first protein with a DAC domain to be
characterized [29]. DisA is found in both Gram-negative and Gram-positive bacteria but is particularly
prevalent in Gram-positive spore-forming bacteria such as Bacillus and Clostridium species. X-ray
crystallography revealed that the DAC domains of two tetrameric DisA molecules interact to
form a stable octameric structure. The direct contact of DAC domains is necessary for c-di-AMP
production [29]. The carboxyl end of DisA enzyme contains a DNA binding domain, and the amino
terminal end possesses a globular domain with catalytic activity. These two domains are connected by
a helical domain [18]. RadA, a DNA repair protein in B. subtilis, is encoded together with DisA in a
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conserved operon, and their close genetic proximity suggests the involvement of DisA in maintaining
DNA integrity [18,32]. Indeed, DisA mutant strains are less able to repair damaged DNA than the
wild type [32,34]. It turned out that DisA is a checkpoint protein that directly regulates DNA repair
mechanisms by responding to DNA damage [18]. During sporulation in B. subtilis, DisA scans DNA
and detects damage of chromosomal breaks via its DNA-binding domain, thereby signaling a stop
in the sporulation process [17,18]. After repairing the DNA damage, c-di-AMP signals to restart the
sporulation pathway [18]. Both high and low c-di-AMP levels impair the DNA binding activity of
DisA [18].
2.2. CdaA
Among the three DACs, CdaA, sometimes referred to as DacA, is the most common as it is
found in a wide variety of bacteria including notable human pathogens S. aureus, S. pneumoniae,
S. pyogenes, and L. monocytogenes [17,39]. c-di-AMP produced by CdaA has been shown to be involved
in maintaining cell wall homeostasis as well as controlling potassium ion channel activity [32]. The cdaA
gene is often located immediately upstream of the gene encoding GlmM, a critical peptidoglycan
biosynthetic enzyme [32,41]. Bacteria that rely solely upon CdaA for c-di-AMP production develop
weakened cell walls, which manifests as a gain in antibiotic resistance when c-di-AMP levels are
altered. Furthermore, alterations in c-di-AMP production results in reduced potassium ion channel
activity (see KtrA below) [41,42]. In B. subtilis, CdaA directly regulates cell wall homeostasis through
interaction with GlmM [38]. The CdaA encoding operon also encodes a regulatory protein CdaR,
and the interaction of CdaA and CdaR regulates potassium ion channel activity [19,38]. Due to its
crucial role in multiple physiological processes, the deletion of the cdaA gene is often unsuccessful or
only possible under certain circumstances (acquisition of secondary suppressor mutations or specific
growth conditions), thus making CdaA an attractive novel target for antibacterial drugs.
2.3. CdaS
The third type of DAC, CdaS, is found only in the spore-forming Bacillus species and one
Clostridium species [32] and is expressed exclusively during spore germination [19]. CdaS-mutant
strains have a two-fold decreased germination rate compared with wild-type strains, but the
mechanism of CdaS-dependent regulation of sporulation has yet to be revealed. CdaS contains two
N-terminal α-helices that are linked to the C-terminal DAC domain [19]. CdaS forms a hexamer that
displays relatively low catalytic activity, but a truncated CdaS engineered to lack one or both helices
results in a monomer that is hyper-active in c-di-AMP production, indicating that the N-terminal
helices are involved in hexamer formation as well as regulation of enzymatic activity.
2.4. CdaM
The fourth class of c-di-AMP synthesizing enzyme, CdaM, has been recently identified in
Mycoplasma pneumoniae through pull-down assay [28]. CdaM only exists in M. pneumoniae, and
it is closely related to the DAC domain of CdaS present in B. subtilis [28]. CdaM mutant strains were
unable to grow, indicating that c-di-AMP is essential for the survival of M. pneumoniae, [28]. In this
bacterium, c-di-AMP also regulates potassium ion transportation. c-di-AMP binds to KtrC, and this
interaction interrupts the activity of the low-affinity potassium ion transporter, KtrCD [28].
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Figure 1. Synthesis and degradation of cyclic di-adenosine monophosphate (c-di-AMP). Diadenylate
cyclase (DAC) enzymes synthesize c-di-AMP through a condensation reaction of two ATP or two
ADP molecules. c-di-AMP binds to specific target proteins, thereby regulating the functions of
downstream proteins within a variety of cellular pathways. To maintain appropriate levels of c-di-AMP,
phosphodiesterases (PDEs) degrade c-di-AMP into pApA, which further degrades into AMP [22,43].
3. c-di-AMP Degradation
Bacteria utilize both synthesis and degradation enzymes to regulate the cellular level of second
messenger molecules. The c-di-AMP hydrolyzing enzyme phosphodiesterase (PDE) was first identified
in B. subtilis and was subsequently found in S. aureus, L. monocytogenes, and Streptococcus species [44,45].
PDE enzymes degrade c-di-AMP, converting it into the linear form of phosphoadenyl adenosine
(pApA), which can then be further degraded into two molecules of AMP [22,43]. Three classes of PDE
are involved in c-di-AMP degradation; GdpP, Pde2 and PgpH [44,45]. The presence of each class of
PDE varies by bacterial species. Some bacteria, such as L. monocytogenes, encode GdpP and PgpH
whereas others, such as Streptococcus and Staphylococcus species, possess GdpP and Pde2 [44]. The PDE
enzymes appear to be stimulated by internal and external stimuli, but the specific stimuli and detailed
mechanisms are not yet known.
3.1. GdpP
The best-characterized PDE, GdpP, contains the catalytic DHH/DHHA1 domain (DHH stands
for Asp-His-His) [44,45]. This domain is primarily found in phosphatases and phosphodiesterases that
regulate the phosphorylation of proteins and breakdown of phosphodiester bonds, respectively [35].
The DHH/DHHA1 domain in GdpP cleaves c-di-AMP into pApA [45]. GdpP is highly specific for
c-di-AMP and has been observed to have only very weak enzymatic activity toward c-di-GMP [16,34,45].
GdpP and GdpP homologs have been identified in most microorganisms that produce c-di-AMP thus
far [45]. The operon containing the gdpP gene appears to be evolutionarily conserved amongst all
GdpP producing bacteria as gdpP is co-transcribed with the genes of ribosomal protein L9 (RpL9)
and a DNA replication protein, DnaC [36,46]. Thus, the co-expression of GdpP, RpL9, and DnaC
likely leads to a decrease in the c-di-AMP level during cell growth and replication [36,46]. GdpP also
possesses a PAS (Per-Arnt-Sim) domain that is involved in phosphodiesterase inhibiting activity. PAS
domains are present in many signaling protein molecules and play critical roles as sensory domains in
signal transduction pathways [45]. The PAS domain in GdpP can bind to heme, which inhibits the
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enzymatic activity of GdpP [47]. GdpP also contains a degenerated c-di-GMP synthesizing domain,
GGDEF. However, this domain is not able to synthesize c-di-GMP, but, rather, is involved in the
degradation of ATP [45]. A mutation in the GGDEF domain causes reduced catalytic activity of GdpP,
thus demonstrating a role of the GGDEF domain in the regulation of GdpP catalytic activity [45].
3.2. PgpH
Another class of phosphodiesterase, PgpH, was first identified in L. monocytogenes, and now
appears to be widespread throughout multiple bacterial phyla [44,48]. PgpH possesses a catalytic
histidine-aspartate domain (HD) in its C-terminus that binds to c-di-AMP with high specificity and
degrades it into 5’-pApA. HD is composed of two subdomains and two active sites that require iron
for their catalytic activity [44]. In addition to an HD domain, PgpH also possesses an N-terminal
extracellular domain and seven transmembrane helices [44,48]. In L. monocytogenes, PgpH and PdeA,
a homolog of GdpP, regulate the intracellular level of c-di-AMP in a cooperative manner. However,
these enzymes are regulated by different external stimuli. PgpH expresses preferably in broth culture
while PdeA is preferentially expressed during intracellular infection of eukaryotic host cells [44].
L. monocytogenes mutants lacking either PgpH or PdeA exhibit slight growth defects compared to the
wild type. However, mutants lacking both pdeA and pgpH exhibit higher levels of c-di-AMP, which is
detrimental to bacterial growth and contributes to reduced virulence of L. monocytogenes in a mouse
model of infection, indicating the cooperative c-di-AMP degradative activity of these two enzymes [44].
The double mutant also elicits increased interferon (IFN) - β during intracellular infection of host
cells [48]. Upon infection, L. monocytogenes induces the expression of β -interferon and co-regulated
genes following stimulation of the cytosolic surveillance pathway (CSP), STING, and DDX41 pathways
in the host immune system [21]. In a screen designed to determine the Pathogen Associated Molecular
Patterns (PAMPs) recognized by the infected mammalian cells, c-di-AMP was identified [16]. Indeed,
bacterial mutants that secrete more c-di-AMP lead to an increase in β-interferon secretion [21].
3.3. Pde2
Pde2 is a recently discovered c-di-AMP degrading enzyme containing a DHH/DHHA1 domain. It
was first identified in S. pneumoniae [43,49] and its enzymatic activity and structures have been studied
in S. aureus [50], Mycobacterium spp. [51–53], and Borrelia burgdoferi [54]. M. pneumoniae, B. burgdorferi,
and M. tuberculosis contain only PDEs of the Pde2 type. Pde2 is a cytoplasmic protein that can degrade
c-di-AMP but preferentially hydrolyzes linear pApA to AMP as demonstrated in S. aureus [43,50].
Deletion of the pde2 gene leads to a rapid increase of intracellular pApA levels compared to the
wild type. pApA and c-di-AMP concentrations are interconnected as pApA inhibits the c-di-AMP
hydrolyzing activity of GdpP [50]. Thus, Pde2 plays a key role in maintaining the homeostasis of
intracellular pApA and c-di-AMP levels that are crucial for the growth and survival of bacteria.
4. c-di-AMP Binding Molecules
Since the diverse roles of c-di-AMP in cell signaling pathways depend upon its binding to target
molecules, the investigation into the identification, structure, and function of c-di-AMP binding
molecules is important to reveal the mechanisms of c-di-AMP activity in various signaling pathways.
However, unlike c-di-GMP for which hundreds of binding proteins have been identified [32,33,55],
a few c-di-AMP binding proteins have been discovered so far in bacteria (Table 2) [17]. Multiple
strategies have been successfully employed to identify c-di-AMP binding proteins including
UV-crosslinking of 32P-labelled c-di-AMP with a library of purified proteins [55]. However, the
most common strategy involves the use of c-di-AMP affinity columns to isolate binding proteins
from bacterial cytoplasmic extracts followed by gel electrophoresis and mass-spectroscopy [17,25,48].
c-di-AMP binding is typically confirmed via standard affinity assays such as surface plasmon
resonance (SPR) or pulse chase analysis [55], or more recently through an adaption of the differential
radial capillary action of ligand assay (DRaCALA) first used to study c-di-GMP binding [17,48].
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These recently identified c-di-AMP binding proteins include enzymes, transporters and transcriptional
regulators that are themselves allosterically regulated by c-di-AMP binding. The structural
analysis of c-di-AMP binding proteins has also facilitated the identification of conserved c-di-AMP
binding-domains, thus leading to the discovery of additional c-di-AMP binding proteins. In addition
to binding proteins, c-di-AMP can bind to RNA riboswitches [56–60].
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4.1. TetR-Family Transcription Factor, DarR
DarR from Mycobacterium smegmatis, a member of the TetR-family regulator proteins, was
identified through a c-di-AMP transcription factor binding screen [38,55]. TetR regulators are DNA
binding proteins whose affinity towards DNA is altered upon interaction with their cognate small
molecule. Following small molecule interaction, these regulators undergo a structural change, thereby
altering their affinity towards specific DNA binding sites and giving rise to the altered expression
of target genes. Like the other members of the TetR family, DarR represses its own promoter as well
as the downstream genes. DarR homologs are found primarily in Gram-positive bacteria such as
Bacillus spp., Staphylococcus spp., Listeria spp., Lactobacillus spp., and Clostridium spp. [38,55].
DarR contains two domains: a C-terminal QacR-like domain, and an N-terminal TetR-like
helix-turn-helix DNA binding domain [38,55]. Interestingly, not all c-di-AMP-producing bacteria
possess QacR-like domains in their DarR proteins. The domain is found in Staphylococcus, B. subtilis,
and Pelotomaculum thermopropionicum [55]. The detailed mechanism of c-di-AMP allosteric regulation
of DarR is not well understood, nor has the binding site of c-di-AMP been identified, but c-di-AMP
has been shown to stimulate the binding of DarR to its target DNA [55]. DarR binds to the promoter
regions of genes that are involved in fatty acid metabolism and the expression of the cold shock
protein in M. smegmatis as darR deleted M. smegmatis exhibits larger cell size and reduced fatty acid
metabolism [38,55].
4.2. RCK_C Domain Protein KtrA
The first c-di-AMP binding protein isolated and characterized from bacterial cytoplasmic extract
through c-di-AMP affinity chromatography was potassium transport protein, KtrA, an RCK (regulator
of conductance of K+) domain-containing protein from S. aureus [17]. RCK domains are commonly
found in potassium ion transport systems and are involved in the regulation of ion channel gating [58].
KtrA possesses two RCK domains, an N-terminal RCK (RCK_N) domain that is able to bind to a
variety of molecules such as ATP, ADP, NAD, and NADH, and a C-terminal RCK (RCK_C) domain
that binds to c-di-AMP [58]. KtrA associates with KtrB, a membrane-integrated protein that forms
the potassium ion channel [65]. c-di-AMP binding to KtrA inhibits potassium transport [17,20,25]
Furthermore, ktrA mutated S. aureus exhibits lower survival rates than the wild type strains when
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bacteria are grown in medium containing low potassium concentrations [17,32]. The link between
c-di-AMP and potassium ion channel proteins is found not only in Staphylococcus strains but also in
Bacillus and Streptococcus species [17,20,25].
4.3. RCK_C Domain Protein CpaA
Another c-di-AMP binding protein isolated from S. aureus is cation-proton antiporter, CpaA [17].
CpaA was identified bioinformatically based on the presence of the RCK domain, as found in KtrA, but
structurally, these two c-di-AMP binding proteins have very low overall identity to each other. CpaA
was confirmed to bind labeled c-di-AMP by DRaCALA assay. CpaA is a predicted cation/proton
anti-porter that exchanges intracellular protons with potassium, but may also transport sodium and
calcium ions [17]. A recent structural study revealed that c-di-AMP binding alters transport activity by
40% [66].
4.4. Histidine Kinase Protein, KdpD
KdpD is yet another c-di-AMP binding protein identified from S. aureus, this time by screening a
recombinant S. aureus ORFeome expression library using DRaCALA [17]. KdpD is a histidine kinase
that functions as a two-component system (TCS) with KdpE, the response regulator. Generally, TCSs
are composed of a histidine kinase and a cognate response regulator. The histidine kinase spans the
cell membrane and senses intracellular or extracellular signals including changes in pH, osmolarity, or
quorum sensing molecules. Upon sensing appropriate stimuli, the histidine kinase transduces this
information via phosphotransfer to a cytosolic response regulator protein that generally functions
as a transcriptional regulator. KdpD has been shown to regulate potassium homeostasis in the cell
by altering the expression of genes involved in the Kdp high-affinity potassium uptake system [62].
This potassium uptake system is ATP-dependent and responds to very low potassium conditions where
other systems cannot support potassium uptake [32]. KdpD-mutated S. aureus displays dysregulated
ion channel systems, which lead to lower virulence and decreased survival of bacteria as compared to
the wild type. c-di-AMP binds to the universal stress protein domain (USP) within the N-terminal
cytoplasmic region of KdpD and inhibits the upregulation of the genes in the Kdp potassium uptake
system under salt stress [67].
4.5. PII-Like Signal Transduction Protein, PstA
Another c-di-AMP binding protein discovered using the ORFeome DRaCALA screening technique
is PstA, first identified in S. aureus but also present in L. monocytogenes and B. subtilis [32,35]. PstA
is a predicted cytoplasmic PII-like signal transduction protein. Among the members of the PII-like
signal transduction proteins, the PII nitrogen regulatory protein is the best characterized. This protein
detects the amount of nitrogen and carbon in cells by sensing glutamine and 2-oxoglutarate levels [64].
The analyses of the crystal structures of PstA in three microorganisms, S. aureus, L. monocytogenes and
B. subtilis revealed that PtsA forms a homotrimer and c-di-AMP binds a pocket located between two
subunits, so three molecules of c-di-AMP bind to the homotrimer [64,68,69].
4.6. KtrA Homolog Protein, CabP
CabP was identified in S. pneumoniae by c-di-AMP affinity chromatography of bacterial cell
lysates [25]. This protein belongs to the potassium ion transporter protein family, Trk , which is involved
in potassium ion transport. CabP has a molecular mass of 24 kDa and is 33% identical to the KtrA
protein by amino acid sequence, both of which form stable octamers in solution [17,25]. The presence
of genes encoding CabP and the KtrB ortholog, SPD_0076, in the same operon in S. pneumoniae further
supports the involvement of CabP in potassium uptake [25]. Indeed, deficiency of either CabP or
SPD_0076 leads to impaired potassium uptake and decreased survival of the bacterium [25]. Using
an E. coli two-hybrid system coupled with coexpression of the c-di-AMP synthesis enzyme DisA
(as E. coli does not normally produce c-di-AMP), c-di-AMP was shown to inhibit the interaction of
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CabP with SPD_0076 and thereby lead to the reduction of potassium uptake [25]. CabP has a high
affinity for c-di-AMP, and the presence of other nucleotides such as cAMP, c-di-GMP, AMP, and pApA
does not decrease the CabP:c-di-AMP binding rate. In the above-mentioned study, Bai et al. isolated
several proteins from the crude cytoplasmic extract of S. pneumoniae and CabP was the most abundant.
This suggests that more c-di-AMP binding proteins still await discovery.
4.7. CabPA and CabPB
Two c-di-AMP binding proteins, CabPA and CabPB have been recently identified in S. mutans
through an affinity chromatography pulldown assay [23]. They belong to the TrkA protein family like
KtrA. TrkA protein family members possess a TrkA_N and a TrkA_C domain, and the TrkA_C domain
has been shown to be a c-di-AMP binding domain. TrkA family proteins are typically involved in
potassium ion transport, but the role of CabPA and CabPB in potassium ion transportation has not
been demonstrated [23]. Peng et al. have uncovered a role of c-di-AMP in the regulation of biofilm
formation through a comparative study of wild type and PdeA-mutated S. mutans strains. Deletion
of pdeA leads to an increase in the intracellular level of c-di-AMP, thereby leading to decreased cell
growth but increased biofilm formation [23]. The cabPA deletion suppresses the increased biofilm
formation by the pdeA deletion [23]. CabPA also interacts with VicR, which is known to regulate the
expression of biofilm matrix protein, GtfB. The interaction among CabPA, VicR and GtfB appears to be
at the center of the biofilm regulatory network controlled by c-di-AMP [23].
4.8. LmPC
c-di-AMP affinity chromatography followed by confirmation with DRaCALA was used to
identify several hypothetical proteins from L. monocytogenes as well as pyruvate carboxylase renamed
LmPC [48]. LmPC is an enzyme used in central carbon metabolism, converting pyruvate to oxaloacetate.
Binding studies revealed a specificity of LmPC for c-di-AMP binding compared with structurally
related di-nucleotides [48]. Furthermore, binding of c-di-AMP to LmPC decreases catalytic activity of
the enzyme, and the LmPC:c-di-AMP interaction therefore regulates various metabolic pathways in
L. monocytogenes including carbon flux through the citric acid cycle as well as glutamate biosynthesis,
processes that are crucial for bacterial survival within the host environment [48]. LmPC is a tetrameric
protein that contains several domains including biotin carboxylase (BC) and carboxyltransferase (CT)
domains. The tetrameric structure of LmPC is composed of two layers of monomers through the strong
interactions of BC and CT domains [48]. Structural analysis revealed that two molecules of c-di-AMP
can bind to the dimer interfaces of two CT domains in a two-fold symmetry in a region of the protein
that was not previously recognized to have any regulatory significance [48]. Mutations within the
c-di-AMP binding site that prevent the LmPC:c-di-AMP interaction alter the catalytic activity of the
carboxylase enzyme domain [48].
4.9. c-di-AMP Binding Riboswitches
Second messenger molecules can bind not only to specific proteins but also to regulatory RNA
molecules known as riboswitches [35,56,58]. Many classes of riboswitches have been identified
bioinformatically based on the presence of conserved RNA motifs within intergenic regions, and have
subsequently been shown to bind a variety of molecules including metals, amino acids, carbohydrates
and other second messenger molecules in the cells, and thereby regulate downstream genes by
pre- or post-transcriptional mechanisms [59]. Riboswitches generally contain a ligand-sensing domain
and an expression platform to facilitate the signal transduction of ligand binding and differential
expression of the regulated genes [56]. Although several riboswitch classes have been identified based
on the presence of RNA motifs, many of them are still considered “orphan” as no ligand as yet been
identified [70].
One well-known riboswitch, the ydaO riboswitch, since one of them exists in the promoter
region of the B. subtilis ydaO gene, was found to be associated with genes that regulate cell wall
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metabolism, osmotic stress, and sporulation. However, the riboswitch ligand remained elusive
for many years until an unbiased search for the ydaO riboswitch binding molecules utilizing
yeast extract as a source of chemically diverse natural metabolites identified AMP as a ligand
with weak affinity, and further refinement led to the identification of c-di-AMP as the primary
ligand [71,72]. A mutagenic study of B. subtilis revealed that the ydaO riboswitch is not essential
for the bacteria and functions as a transcription terminator in the c-di-AMP bound state. During
times of increased c-di-AMP concentration, the riboswitch can act as a genetic off switch to turn
off gene expression. The ligand-binding domain of the ydaO riboswitch possesses highly conserved
residues for c-di-AMP recognition. It also exhibits a novel platform in the c-di-AMP bound state that
includes pseudo-two-fold symmetry of the RNA and a very stable conformation formed after binding
to two c-di-AMP molecules [57,59]. The binding of two c-di-AMP molecules provides a very stable
riboswitch conformation, which supports the idea that two c-di-AMP molecules work cooperatively.
This conformation reveals that the binding pattern of c-di-AMP to a riboswitch is very different from
the binding of c-di-AMP to proteins.
The ydaO riboswitch is currently the only known c-di-AMP binding riboswitch. Although
the riboswitch motif is widely distributed in many bacteria, ydaO is present only in some bacteria
that produce c-di-AMP, namely Bacillus and Clostridium species. The ydaO riboswitch has not been
found in Lactococcus, Listeria, Staphylococcus, or Streptococcus [35]. Interestingly, in B. subtilis, the ydaO
riboswitch is located within the ktrAB transcript, which encodes a potassium ion transporter (see above),
and the kimA (aka ydaO) transcript, which encodes a high affinity potassium ion transporter [73].
The c-di-AMP -riboswitch interaction negatively controls the expression of kimA. High levels of
extracellular K+ increases the intracellular c-di-AMP concentration, which, in turn, represses the
expression of riboswitch controlled genes in the potassium transport system [73].
5. Conclusions
Second messenger molecules are critical elements in signal transduction pathways utilized by
many organisms. They are involved in the regulation of various key cellular processes in both
prokaryotes and eukaryotes. In recent years, c-di-AMP signaling has been identified as a central
factor in many Gram-positive bacteria regulating cell wall synthesis, potassium ion channels, DNA
repair, and biofilm formation [32]. c-di-AMP is also essential for cell growth, survival, and virulence
of several well-known human pathogenic bacteria including S. aureus, L. monocytogenes, S. pyogenes,
and Mycobacterium spp. [17,20,22,26,35]. Although many cellular functions of c-di-AMP are known,
the detailed mechanisms of the cellular processes have yet to be revealed. The c-di-AMP synthesizing
enzymes and degradation enzymes regulate the homeostasis of intracellular c-di-AMP levels. Four
classes of DAC (DisA, CdaA, CdaS, and CdaM) and three types of PDE (Gdpp, Pde2 and PgpH) are
found in c-di-AMP-producing bacteria, and the types of enzymes and their functions vary by bacterial
species [1,32]. Due to their essential role in bacteria, the construction of DAC mutant strains is often
difficult. For example, the construction of DAC deletion strains in L. monocytogenes was not possible
in rich media unless accompanied by a secondary mutation in guanosine pentaphosphate (ppGpp)
synthases. Similarly, simultaneous depletion of all three DACs in B. subtilis was synthetic-lethal [36].
However, deletion of the DAC enzyme in S. mutans was not lethal, so c-di-AMP might be not essential
for the growth of some bacteria even under standard lab growth conditions.
Unlike the c-di-GMP network, where more than twenty enzymes are involved in the production
and degradation of the cyclic di-nucleotide, the c-di-AMP synthesis and hydrolysis network appears
much less complex. DACs and PDEs regulate intracellular c-di-AMP homeostasis, while the
receptor proteins and RNA are the key factors that carry out the cellular processes upon binding
to c-di-AMP [32,35]. As DAC is often an essential enzyme in many bacteria, many roles of c-di-AMP
in cellular processes have been revealed by examining PDE mutant strains. The alteration of c-di-AMP
levels following PDE depletion often results in decreased survival of the bacteria. Furthermore,
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altered cell wall synthesis and dysregulation of potassium uptake have been observed in PDE mutant
strains [17].
To understand the regulatory network of c-di-AMP at the cellular level, further intensive molecular
studies are necessary. Research has been directed towards the characterization of the receptor molecules
to decipher the regulation mechanisms by c-di-AMP. Several proteins and one type of RNA molecule
have so far been identified that bind to c-di-AMP (Table 2) [32,35]. It appears that there is not much
overlap between c-di-AMP binding proteins among bacteria except the proteins involved in potassium
ion homeostasis. Thus, identifying c-di-AMP-binding proteins using the bacteria previously not
studied might discover new types of c-di-AMP-binding proteins, resulting in discovering new cellular
pathways controlled by c-di-AMP. The only c-di-AMP-binding RNA identified so far is the ydaO
riboswitch, and many bacteria producing c-di-AMP do not contain this riboswitch. New types of
c-di-AMP-binding RNAs might also be discovered by the screening of c-di-AMP-binding RNA in
those bacteria. Thus, investigations with diverse organisms might lead to a better understanding of
the mechanisms of regulation in c-di-AMP signaling pathways. The specific environmental stimuli in
c-di-AMP signaling pathways are still a mystery, so identifying the signals is also necessary for better
understanding of how bacteria sense environmental stimuli and adapt to environmental changes.
Agents that disrupt c-di-AMP signaling, such as inhibitors of DACs and PDEs, may also prove useful
for antibacterial therapy in the future.
Acknowledgments: We would like to thank Stephanie Pitman and Martha Port for proofreading of the manuscript.
Author Contributions: All authors contributed equally to this article.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Hengge, R.; Grundling, A.; Jenal, U.; Ryan, R.; Yildiz, F. Bacterial signal transduction by cyclic di-GMP and
other nucleotide second messengers. J. Bacteriol. 2016, 198, 15–26. [CrossRef] [PubMed]
2. Kalia, D.; Merey, G.; Nakayama, S.; Zheng, Y.; Zhou, J.; Luo, Y.L.; Guo, M.; Roembke, B.T.; Sintim, H.O.
Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in
pathogenesis. Chem. Soc. Rev. 2013, 42, 305–341. [CrossRef] [PubMed]
3. Pesavento, C.; Hengge, R. Bacterial nucleotide-based second messengers. Curr. Opin. Microbiol. 2009, 12,
170–176. [CrossRef] [PubMed]
4. Huynh, T.N.; Choi, P.H.; Sureka, K.; Ledvina, H.E.; Campillo, J.; Tong, L.; Woodward, J.J. Cyclic di-AMP
targets the cystathionine beta-synthase domain of the osmolyte transporter OpuC. Mol. Microbiol. 2016, 102,
233–243. [CrossRef] [PubMed]
5. Sutherland, E.W.; Rall, T.W. Fractionation and characterization of a cyclic adenine ribonucleotide formed by
tissue particles. J. Biol. Chem. 1958, 232, 1077–1091. [PubMed]
6. Rall, T.W.; Sutherland, E.W. Formation of a cyclic adenine ribonucleotide by tissue particles. J. Biol. Chem.
1958, 232, 1065–1076. [PubMed]
7. McDonough, K.A.; Rodriguez, A. The myriad roles of cyclic AMP in microbial pathogens: From signal to
sword. Nat. Rev. Microbiol. 2011, 10, 27–38. [CrossRef] [PubMed]
8. Gomelsky, M.; Galperin, M.Y. Bacterial second messengers, cGMP and c-di-GMP, in a quest for regulatory
dominance. Embo J. 2013, 32, 2421–2423. [CrossRef] [PubMed]
9. Gomelsky, M. cAMP, c-di-GMP, c-di-AMP and now cGMP: Bacteria use them all! Mol. Microbiol. 2011, 79,
562–565. [CrossRef] [PubMed]
10. Andrade, W.A.; Firon, A.; Schmidt, T.; Hornung, V.; Fitzgerald, K.A.; Kurt-Jones, E.A.; Trieu-Cuot, P.;
Golenbock, D.T.; Kaminski, P.A. Group B Streptococcus degrades cyclic-di-AMP to modulate
STING-dependent type I interferon production. Cell HostMicrobe 2016, 20, 49–59. [CrossRef] [PubMed]
11. Barker, J.R.; Koestler, B.J.; Carpenter, V.K.; Burdette, D.L.; Waters, C.M.; Vance, R.E.; Valdivia, R.H.
STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during
Chlamydia trachomatis infection. Mbio 2013, 4, e00018-13. [CrossRef] [PubMed]
Genes 2017, 8, 197 14 of 17
12. Corrigan, R.M.; Abbott, J.C.; Burhenne, H.; Kaever, V.; Grundling, A. c-di-AMP is a new second messenger
in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog. 2011, 7, e1002217.
[CrossRef] [PubMed]
13. Gandara, C.; Alonso, J.C. DisA and c-di-AMP act at the intersection between DNA-damage response and
stress homeostasis in exponentially growing Bacillus subtilis cells. DNA Repair 2015, 27, 1–8. [CrossRef]
[PubMed]
14. Kamegaya, T.; Kuroda, K.; Hayakawa, Y. Identification of a Streptococcus pyogenes SF370 gene involved in
production of c-di-AMP. Nagoya J. Med. Sci. 2011, 73, 49–57. [PubMed]
15. Pham, T.H.; Liang, Z.X.; Marcellin, E.; Turner, M.S. Replenishing the cyclic-di-AMP pool: Regulation of
diadenylate cyclase activity in bacteria. Curr. Genet. 2016, 62, 731–738. [CrossRef] [PubMed]
16. Woodward, J.J.; Iavarone, A.T.; Portnoy, D.A. c-di-AMP secreted by intracellular Listeria monocytogenes
activates a host type I interferon response. Science 2010, 328, 1703–1705. [CrossRef] [PubMed]
17. Corrigan, R.M.; Campeotto, I.; Jeganathan, T.; Roelofs, K.G.; Lee, V.T.; Grundling, A. Systematic identification
of conserved bacterial c-di-AMP receptor proteins. Proc. Natl. Acad. Sci. USA 2013, 110, 9084–9089.
[CrossRef] [PubMed]
18. Oppenheimer-Shaanan, Y.; Wexselblatt, E.; Katzhendler, J.; Yavin, E.; Ben-Yehuda, S. c-di-AMP reports DNA
integrity during sporulation in Bacillus subtilis. Embo Rep. 2011, 12, 594–601. [CrossRef] [PubMed]
19. Mehne, F.M.P.; Schroder-Tittmann, K.; Eijlander, R.T.; Herzberg, C.; Hewitt, L.; Kaever, V.; Lewis, R.J.;
Kuipers, O.P.; Tittmann, K.; Stulke, J. Control of the diadenylate cyclase CdaS in Bacillus subtilis: An
autoinhibitory domain limits cyclic di-AMP production. J.Biol. Chem. 2014, 289, 21098–21107. [CrossRef]
[PubMed]
20. Gundlach, J.; Rath, H.; Herzberg, C.; Mader, U.; Stulke, J. Second messenger signaling in Bacillus subtilis:
Accumulation of cyclic di-AMP inhibits biofilm formation. Front. Microbiol. 2016, 7, 804. [CrossRef]
[PubMed]
21. Witte, C.E.; Whiteley, A.T.; Burke, T.P.; Sauer, J.D.; Portnoy, D.A.; Woodward, J.J. Cyclic di-AMP is critical for
Listeria monocytogenes growth, cell wall homeostasis, and establishment of infection. Mbio 2013, 4, e00282-13.
[CrossRef] [PubMed]
22. Manikandan, K.; Sabareesh, V.; Singh, N.; Saigal, K.; Mechold, U.; Sinha, K.M. Two-step synthesis and
hydrolysis of cyclic di-AMP in Mycobacterium tuberculosis. PLoS ONE 2014, 9, e86096. [CrossRef] [PubMed]
23. Peng, X.; Zhang, Y.; Bai, G.C.; Zhou, X.D.; Wu, H. Cyclic di-AMP mediates biofilm formation. Mol. Microbiol.
2016, 99, 945–959. [CrossRef] [PubMed]
24. Cheng, X.Q.; Zheng, X.; Zhou, X.D.; Zeng, J.M.; Ren, Z.; Xu, X.; Cheng, L.; Li, M.Y.; Li, J.Y.; Li, Y.Q.
Regulation of oxidative response and extracellular polysaccharide synthesis by a diadenylate cyclase in
Streptococcus mutans. Environ. Microbiol. 2016, 18, 904–922. [CrossRef] [PubMed]
25. Bai, Y.L.; Yang, J.; Zarrella, T.M.; Zhang, Y.; Metzger, D.W.; Bai, G.C. Cyclic di-AMP impairs potassium
uptake mediated by a cyclic di-AMP binding protein in Streptococcus pneumoniae. J. Bacteriol. 2014, 196,
614–623. [CrossRef] [PubMed]
26. Cho, K.H.; Kang, S.O. Streptococcus pyogenes c-di-AMP phosphodiesterase, GdpP, influences SpeB processing
and virulence. PLoS ONE 2013, 8, e69425. [CrossRef] [PubMed]
27. Bin, D.; Ji, W.H.; An, H.T.; Shi, Y.B.; Huang, Q.Q.; Cheng, Y.Q.; Fu, Q.; Wang, H.G.; Yan, Y.X.; Sun, J.H.
Functional analysis of c-di-AMP phosphodiesterase, GdpP, in Streptococcus suis serotype 2. Microbiol. Res.
2014, 169, 749–758.
28. Blötz, C.; Treffon, K.; Kaever, V.; Schwede, F.; Hammer, E.; Stülke, J. Identification of the components involved
in cyclic di-AMP signaling in Mycoplasma pneumoniae. Front. Microbiol. 2017, 8, 1328. [CrossRef] [PubMed]
29. Witte, G.; Hartung, S.; Buttner, K.; Hopfner, K.P. Structural biochemistry of a bacterial checkpoint protein
reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol. Cell 2008, 30,
167–178. [CrossRef] [PubMed]
30. Opoku-Temeng, C.; Zhou, J.; Zheng, Y.; Su, J.; Sintim, H.O. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and
cGAMP) signalings have come of age to be inhibited by small molecules. Chem. Commun. 2016, 52, 9327–9342.
[CrossRef] [PubMed]
31. Whiteley, A.T.; Pollock, A.J.; Portnoy, D.A. The PAMP c-di-AMP Is essential for Listeria monocytogenes growth
in rich but not minimal media due to a toxic increase in (p)ppGpp. Cell Host Microbe 2015, 18, 132. [CrossRef]
Genes 2017, 8, 197 15 of 17
32. Corrigan, R.M.; Grundling, A. Cyclic di-AMP: Another second messenger enters the fray. Nat. Rev. Microbiol.
2013, 11, 513–524. [CrossRef] [PubMed]
33. Romling, U.; Galperin, M.Y.; Gomelsky, M. Cyclic di-GMP: The first 25 years of a universal bacterial second
messenger. Microbiol. Mol. Biol. Rev. 2013, 77, 1–52. [CrossRef] [PubMed]
34. Huynh, T.N.; Woodward, J.J. Too much of a good thing: Regulated depletion of c-di-AMP in the bacterial
cytoplasm. Curr. Opin. Microbiol. 2016, 30, 22–29. [CrossRef] [PubMed]
35. Commichau, F.M.; Dickmanns, A.; Gundlach, J.; Ficner, R.; Stulke, J. A jack of all trades: The multiple roles of
the unique essential second messenger cyclic di-AMP. Mol. Microbiol. 2015, 97, 189–204. [CrossRef] [PubMed]
36. Luo, Y.; Helmann, J. Analysis of the role of Bacillus subtilis σ(M) in β-lactam resistance reveals an essential
role for c-di-AMP in peptidoglycan homeostasis. Mol. Microbiol. 2012, 83, 623–639. [CrossRef] [PubMed]
37. Bai, Y.; Yang, J.; Zhou, X.; Ding, X.; Eisele, L.E.; Bai, G. Mycobacterium tuberculosis Rv3586 (DacA) is a
diadenylate cyclase that converts ATP or ADP into c-di-AMP. PLoS ONE 2012, 7, e35206. [CrossRef]
[PubMed]
38. Gundlach, J.; Mehne, F.M.P.; Herzberg, C.; Kampf, J.; Valerius, O.; Kaever, V.; Stulke, J. An essential poison:
Synthesis and degradation of cyclic di-AMP in Bacillus subtilis. J. Bacteriol. 2015, 197, 3265–3274. [CrossRef]
[PubMed]
39. Rosenberg, J.; Dickmanns, A.; Neumann, P.; Gunka, K.; Arens, J.; Kaever, V.; Stulke, J.; Ficner, R.;
Commichau, F.M. Structural and biochemical analysis of the essential diadenylate cyclase CdaA from
Listeria monocytogenes. J. Biol. Chem. 2015, 290, 6596–6606. [CrossRef] [PubMed]
40. Punta, M.; Coggill, P.C.; Eberhardt, R.Y.; Mistry, J.; Tate, J.; Boursnell, C.; Pang, N.; Forslund, K.; Ceric, G.;
Clements, J.; et al. The Pfam protein families database. Nucleic Acids Res. 2012, 40, D290–D301. [CrossRef]
[PubMed]
41. Corrigan, R.M.; Bowman, L.; Willis, A.R.; Kaever, V.; Grundling, A. Cross-talk between two
nucleotide-signaling pathways in Staphylococcus aureus. J. Biol. Chem. 2015, 290, 5826–5839. [CrossRef]
[PubMed]
42. Zhu, Y.; Pham, T.H.; Nhiep, T.H.; Vu, N.M.; Marcellin, E.; Chakrabortti, A.; Wang, Y.; Waanders, J.; Lo, R.;
Huston, W.M.; et al. Cyclic-di-AMP synthesis by the diadenylate cyclase CdaA is modulated by the
peptidoglycan biosynthesis enzyme GlmM in Lactococcus lactis. Mol. Microbiol. 2016, 99, 1015–1027.
[CrossRef] [PubMed]
43. Bai, Y.L.; Yang, J.; Eisele, L.E.; Underwood, A.J.; Koestler, B.J.; Waters, C.M.; Metzger, D.W.; Bai, G.C. Two
DHH subfamily 1 proteins in Streptococcus pneumoniae possess cyclic di-AMP phosphodiesterase activity and
affect bacterial growth and virulence. J. Bacteriol. 2013, 195, 5123–5132. [CrossRef] [PubMed]
44. Huynh, T.N.; Luo, S.K.; Pensinger, D.; Sauer, J.D.; Tong, L.; Woodward, J.J. An HD-domain phosphodiesterase
mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence. Proc. Natl. Acad.
Sci. USA 2015, 112, E747–E756. [CrossRef] [PubMed]
45. Rao, F.; See, R.Y.; Zhang, D.W.; Toh, D.C.; Ji, Q.; Liang, Z.X. YybT is a signaling protein that contains a cyclic
dinucleotide phosphodiesterase domain and a GGDEF domain with ATPase activity. J. Biol. Chem. 2010, 286,
29441. [CrossRef] [PubMed]
46. Lou, Y.; Helmann, J. A σD-dependent antisense transcript modulates expression of the cyclic-di-AMP
hydrolase GdpP in Bacillus subtilis. Microbiology 2012, 158, 2732–2741.
47. Tan, E.; Rao, F.; Pasunooti, S.; Pham, T.H.; Soehano, I.; Turner, M.S.; Liew, C.W.; Lescar, J.; Pervushin, K.;
Liang, Z.X. Solution structure of the PAS domain of a thermophilic YybT protein homolog reveals a potential
ligand-binding site. J. Biol. Chem. 2013, 288, 11949–11959. [CrossRef] [PubMed]
48. Sureka, K.; Choi, P.H.; Precit, M.; Delince, M.; Pensinger, D.A.; Huynh, T.N.; Jurado, A.R.; Goo, Y.A.;
Sadilek, M.; Iavarone, A.T.; et al. The cyclic dinucleotide c-di-AMP Is an allosteric regulator of metabolic
enzyme function. Cell 2014, 158, 1389–1401. [CrossRef] [PubMed]
49. Cron, L.E.; Stol, K.; Burghout, P.; van Seim, S.; Simonetti, E.R.; Bootsma, H.J.; Hermans, P.W.M. Two DHH
subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal
disease. Infect. Immun. 2012, 80, 2974.
50. Bowman, L.; Zeden, M.S.; Schuster, C.F.; Kaever, V.; Grundling, A. New insights into the cyclic di-adenosine
monophosphate (c-di-AMP) degradation pathway and the requirement of the cyclic dinucleotide for acid
stress resistance in Staphylococcus aureus. J. Biol. Chem. 2016, 291, 26970–26986. [CrossRef] [PubMed]
Genes 2017, 8, 197 16 of 17
51. He, Q.; Wang, F.; Liu, S.; Zhu, D.; Cong, H.; Gao, F.; Li, B.; Wang, H.; Lin, Z.; Liao, J.; et al. Structural
and biochemical insight into the mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP
phosphodiesterase. J. Biol. Chem. 2016, 291, 14386–14387. [CrossRef] [PubMed]
52. Tang, Q.; Luo, Y.; Zheng, C.; Yin, K.; Ali, M.K.; Li, X.; He, J. Functional analysis of a c-di-AMP-specific
phosphodiesterase MsPDE from Mycobacterium smegmatis. Int. J. Biol. Sci. 2015, 11, 813–824. [CrossRef]
[PubMed]
53. Yang, J.; Bai, Y.L.; Zhang, Y.; Gabrielle, V.D.; Jin, L.; Bai, G.C. Deletion of the cyclic di-AMP phosphodiesterase
gene (cnpB) in Mycobacterium tuberculosis leads to reduced virulence in a mouse model of infection.
Mol. Microbiol. 2014, 93, 65–79. [CrossRef] [PubMed]
54. Ye, M.; Zhang, J.J.; Fang, X.; Lawlis, G.B.; Troxell, B.; Zhou, Y.; Gomelsky, M.; Lou, Y.; Yang, X.F. DhhP, a cyclic
di-AMP phosphodiesterase of Borrelia burgdorferi, is essential for cell growth and virulence. Infect. Immun.
2014, 82, 1840–1849. [CrossRef] [PubMed]
55. Zhang, L.; Li, W.H.; He, Z.G. DarR, a TetR-like transcriptional factor, is a cyclic di-AMP-responsive repressor
in Mycobacterium smegmatis. J. Biol. Chem. 2013, 288, 3085–3096. [CrossRef] [PubMed]
56. Sudarsan, N.; Lee, E.R.; Weinberg, Z.; Moy, R.H.; Kim, J.N.; Link, K.H.; Breaker, R.R. Riboswitches in
eubacteria sense the second messenger cyclic di-GMP. Science 2008, 321, 411–413. [CrossRef] [PubMed]
57. Ren, A.M.; Patel, D.J. c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets.
Nat. Chem. Biol. 2014, 10, 780–786. [CrossRef] [PubMed]
58. Kim, H.; Youn, S.J.; Kim, S.O.; Ko, J.; Lee, J.O.; Choi, B.S. Structural studies of potassium transport protein
KtrA regulator of conductance of K+ (RCK) C domain in complex with cyclic diadenosine monophosphate
(c-di-AMP). J. Biol. Chem. 2015, 290, 16393–16402. [CrossRef] [PubMed]
59. Gao, A.; Serganov, A. Structural insights into recognition of c-di-AMP by the ydaO riboswitch. Nat. Chem. Biol.
2014, 10, 787–792. [CrossRef] [PubMed]
60. Jones, C.P.; Ferre-D’Amare, A.R. Crystal structure of a c-di-AMP riboswitch reveals an internally
pseudo-dimeric RNA. Embo J. 2014, 33, 2692–2703. [CrossRef] [PubMed]
61. Smith, W.M.; Pham, T.H.; Lei, L.; Dou, J.C.; Soomro, A.H.; Beatson, S.A.; Dykes, G.A.; Turner, M.S. Heat
resistance and salt hypersensitivity in Lactococcus lactis due to spontaneous mutation of llmg_1816 (gdpP)
induced by high-temperature growth. Appl. Environ. Microbiol. 2012, 78, 7753–7759. [CrossRef] [PubMed]
62. Freeman, Z.N.; Dorus, S.; Waterfield, N.R. The KdpD/KdpE two-component system: Integrating K+
homeostasis and virulence. PLoS Pathog. 2013, 9, e1003201. [CrossRef] [PubMed]
63. Ballal, A.; Basu, B.; Apte, S.K. The Kdp-ATPase system and its regulation. J. Biosci. 2007, 32, 559–568.
[CrossRef] [PubMed]
64. Choi, P.H.; Sureka, K.; Woodward, J.J.; Tong, L. Molecular basis for the recognition of cyclic-di-AMP by PstA,
a PII-like signal transduction protein. Microbiologyopen 2015, 4, 361–374. [CrossRef] [PubMed]
65. Vieira-Pires, R.S.; Szollosi, A.; Morais-Cabral, J.H. The structure of the KtrAB potassium transporter. Nature
2013, 496, 323–328. [CrossRef] [PubMed]
66. Chin, K.H.; Liang, J.M.; Yang, J.G.; Shih, M.S.; Tu, Z.L.; Wang, Y.C.; Sun, X.H.; Hu, N.J.; Liang, Z.X.; Dow, J.M.;
et al. Structural insights into the distinct binding mode of cyclic di-AMP with SaCpaA_RCK. Biochemistry
2015, 54, 4936–4951. [CrossRef] [PubMed]
67. Moscoso, J.A.; Schramke, H.; Zhang, Y.; Tosi, T.; Dehbi, A.; Jung, K.; Grundling, A. Binding of cyclic
di-AMP to the Staphylococcus aureus sensor kinase KdpD occurs via the universal stress protein domain and
downregulates the expression of the Kdp potassium transporter. J. Bacteriol. 2015, 198, 98–110. [CrossRef]
[PubMed]
68. Campeotto, I.; Zhang, Y.; Mladenov, M.G.; Freemont, P.S.; Grundling, A. Complex structure and biochemical
characterization of the Staphylococcus aureus cyclic diadenylate monophosphate (c-di-AMP)-binding protein
PstA, the founding member of a new signal transduction protein family. J. Biol. Chem. 2015, 290, 2888–2901.
[CrossRef] [PubMed]
69. Gundlach, J.; Dickmanns, A.; Schroder-Tittmann, K.; Neumann, P.; Kaesler, J.; Kampf, J.; Herzberg, C.;
Hammer, E.; Schwede, F.; Kaever, V.; et al. Identification, characterization, and structure analysis of the cyclic
di-AMP-binding PII-like signal transduction protein DarA. J. Biol. Chem. 2015, 290, 3069–3080. [CrossRef]
[PubMed]
Genes 2017, 8, 197 17 of 17
70. Barrick, J.E.; Corbino, K.A.; Winkler, W.C.; Nahvi, A.; Mandal, M.; Collins, J.; Lee, M.; Roth, A.; Sudarsan, N.;
Jona, I.; et al. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control.
Proc. Natl. Acad. Sci. USA 2004, 101, 6421–6426. [CrossRef] [PubMed]
71. Watson, P.Y.; Fedor, M.J. The ydaO motif is an ATP-sensing riboswitch in Bacillus subtilis. Nat. Chem. Biol.
2012, 8, 963–965. [CrossRef] [PubMed]
72. Nelson, J.W.; Sudarsan, N.; Furukawa, K.; Weinberg, Z.; Wang, J.X.; Breaker, R.R. Riboswitches in eubacteria
sense the second messenger c-di-AMP. Nat. Chem. Biol. 2013, 9, 834–839. [CrossRef] [PubMed]
73. Gundlach, J.; Herzberg, C.; Kaever, V.; Gunka, K.; Hoffmann, T.; Weiß, M.; Gibhardt, J.; Thurmer, A.;
Hertel, D.; Daniel, R.; et al. Control of potassium homeostasis is an essential function of the second
messenger cyclic di-AMP in Bacillus subtilis. Sci. Signal. 2017, 10, eaal3011. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
